磷丙泊酚二钠的药理学特性及临床应用进展
Pharmacological characteristic and clinical application progress of fospropofol disodium
磷丙泊酚二钠为丙泊酚前体药物,主要经内皮细胞产生的碱性磷酸酶代谢转换为丙泊酚,进而发挥麻醉镇静作用。磷丙泊酚二钠为水溶性,可降低泵注过程中细菌污染的概率,减轻静脉注射时的疼痛感,且不会引发高脂血症等。此外,其药代动力学稳定,相较于丙泊酚,起效稍慢,作用时间长,镇静深度可预测且可控性好,对呼吸和循环的影响较小。目前已证实,磷丙泊酚二钠可安全用于全身麻醉的诱导与维持、监护下麻醉及 ICU 镇静,尤其适用于老年患者和循环功能不全人群的麻醉。
Fospropofol disodium, a prodrug of propofol, is primarily metabolized to propofol via alkaline phosphatase secreted by endothelial cells, thus exerting anesthetic and sedative effects. Fospropofol disodium is water-soluble, which may reduce the risk of bacterial contamination during infusion, alleviate intravenous injection pain, and avoid complications such as hyperlipidemia. Meanwhile, fospropofol disodium has stable pharmacokinetic characteristics. Compared with propofol, it has a slightly slower onset but a longer duration of action, with predictable and well-controllable sedation depth, and milder effects on the respiratory and circulatory systems. Currently, it has been confirmed that fospropofol disodium can be safely used for induction and maintenance of general anesthesia, monitored anesthesia care, and ICU sedation, and is particularly suitable for elderly patients and populations with circulatory insufficiency.
| [1] |
磷丙泊酚二钠临床应用指导意见专家组. 磷丙泊酚二钠临床应用指导意见[J]. 中华麻醉学杂志, 2023, 43(8): 912-915. DOI: 10.3760/cma.j.cn131073.20230727.00803. |
| [2] |
|
| [3] |
|
| [4] |
何涛, 王永徽, 付静文, |
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
刘佳琦. 磷丙泊酚二钠用于全身麻醉诱导与维持的有效性和安全性观察[D]. 合肥: 安徽医科大学, 2024. |
| [10] |
|
| [11] |
张东浩, 李金辉, 班儒孟, |
| [12] |
李金辉. 磷丙泊酚二钠与丙泊酚用于成人全麻诱导与维持的临床研究[D]. 长春: 吉林大学, 2023. |
| [13] |
|
| [14] |
|
| [15] |
白清海, 张强, 梁亮亮, |
| [16] |
|
| [17] |
|
| [18] |
Gao XH, Yang XB, |
| [19] |
Gao XH, Gao CG, Fang XZ, |
| [20] |
|
| [21] |
依托咪酯临床应用指导意见专家组. 依托咪酯临床应用指导意见 (2023 版)[J]. 国际麻醉学与复苏杂志, 2024, 45(3): 225-232. DOI: 10.3760/cma.j.cn321761-20240118-00985. |
| [22] |
李薇, 杨秀丽, 刘伟钜, |
| [23] |
司悦, 冯嘉琪, 夏莉. 磷丙泊酚二钠用于老年输尿管镜碎石术患者全麻诱导的价值[J]. 河南外科学杂志, 2024, 30(3): 47-49. DOI: 10.16193/j.cnki.hnwk.2024.03.052. |
| [24] |
|
| [25] |
|
| [26] |
王梦媛. 磷丙泊酚二钠孕期药代动力学及组织屏障透过研究[D]. 石家庄: 河北医科大学, 2024. |
| [27] |
|
| [28] |
|
| [29] |
何毕晨, 王超, 岳珍, |
| [30] |
杨曦仑, 彭潇仪, 冯钰铎, |
| [31] |
黄清华, 罗朝志. 不同剂量磷丙泊酚钠后处理对大鼠肝脏缺血再灌注损伤的影响[J]. 华西医学, 2013, 28(5): 741-745. DOI: 10.7507/1002-0179.20130229. |
| [32] |
|
| [33] |
张未, 付静文, 王永徽, |
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
河北省卫生健康委基金项目(20220579)
/
| 〈 |
|
〉 |